Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1974 Jan;16(1):1–12.

Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection.

T H The, G Klein, M M Langenhuysen
PMCID: PMC1553979  PMID: 4143184

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gergely L., Klein G., Ernberg I. Host cell macromolecular synthesis in cells containing EBV-induced early antigens, studied by combined immunofluorescence and radioautography. Virology. 1971 Jul;45(1):22–29. doi: 10.1016/0042-6822(71)90108-5. [DOI] [PubMed] [Google Scholar]
  2. Gergely L., Klein G., Ernberg I. The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines. Int J Cancer. 1971 Mar 15;7(2):293–302. doi: 10.1002/ijc.2910070214. [DOI] [PubMed] [Google Scholar]
  3. Henle G., Henle W., Klein G., Gunven P., Clifford P., Morrow R. H., Ziegler J. L. Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. J Natl Cancer Inst. 1971 Apr;46(4):861–871. [PubMed] [Google Scholar]
  4. Henle W., Henle G., Niederman J. C., Klemola E., Haltia K. Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis. J Infect Dis. 1971 Jul;124(1):58–67. doi: 10.1093/infdis/124.1.58. [DOI] [PubMed] [Google Scholar]
  5. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 1970 Jul 10;169(3941):188–190. doi: 10.1126/science.169.3941.188. [DOI] [PubMed] [Google Scholar]
  6. Klein G. Herpesviruses and oncogenesis. Proc Natl Acad Sci U S A. 1972 Apr;69(4):1056–1064. doi: 10.1073/pnas.69.4.1056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Langenhuysen M. M., The T. H., Nieweg H. O., Kapsenberg J. G. Demonstration of IgM cytomegalovirus-antibodies as an aid to early diagnosis in adults. Clin Exp Immunol. 1970 Mar;6(3):387–393. [PMC free article] [PubMed] [Google Scholar]
  8. Meléndez L. V., Daniel M. D., Hunt R. D., Fraser C. E., Garciá F. G., King N. W., Williamson M. E. Herpesvirus saimiri. V. Further evidence to consider this virus as the etiological agent of a lethal disease in primates which resembles a malignant lymphoma. J Natl Cancer Inst. 1970 May;44(5):1175–1181. [PubMed] [Google Scholar]
  9. Schwartz R. S. Immunoregulation, oncogenic viruses, and malignant lymphomas. Lancet. 1972 Jun 10;1(7763):1266–1269. doi: 10.1016/s0140-6736(72)90985-3. [DOI] [PubMed] [Google Scholar]
  10. The T. H., Feltkamp T. E. Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method. Immunology. 1970 Jun;18(6):875–881. [PMC free article] [PubMed] [Google Scholar]
  11. The T. H., Langenhuysen M. M. Antibodies against membrane antigens of cytomegalovirus infected cells in sera of patients with a cytomegalovirus infection. Clin Exp Immunol. 1972 Aug;11(4):475–482. [PMC free article] [PubMed] [Google Scholar]
  12. Weller T. H. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I. N Engl J Med. 1971 Jul 22;285(4):203–214. doi: 10.1056/NEJM197107222850406. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES